Skip to main content

Advertisement

SpringerLink
Log in

Acute myeloid leukemia associated with FGFR1 abnormalities

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Hematologic malignancies associated with FGFR1 abnormalities present in heterogeneous forms, including myeloproliferative neoplasm, acute myeloid leukemia (AML), T- or B-lineage lymphoblastic leukemia/lymphoma, and even mixed phenotype acute leukemia. In the present report, we describe three new cases of AML associated with FGFR1 abnormalities: AML with minimal differentiation with 45,XY,-7,t(8;13)(p11.2;q12), acute myelomonocytic leukemia with eosinophilia with 48,XY,t(8;9)(p11.2;q33),+19,+21, and AML with minimal differentiation with 46,XX,add(8)(p11.2). FGFR1 abnormalities were confirmed by fluorescence in situ hybridization. We reviewed the records of 19 patients reported from Asian countries, and found that approximately 40 % of cases manifested as acute leukemia associated with myeloid lineage, and 47 % were not accompanied with eosinophilia. These findings highlight the need for detection of FGFR1 abnormalities, not only in myeloproliferative disorder, but also in AML patients even without eosinophilia. The prognosis for this group of neoplasms is poor, and there is no recognized effective targeted treatment. Two patients, including our case, who received allogeneic hematopoietic stem cell transplantation (allo-HSCT) survived. Accumulation of long-term follow-up data can help determine the allo-HSCT protocol or the need for new therapeutic trials to improve the survival rate of patients with FGFR1 abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Hu S, He Y, Zhu X, Li J, He H. Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature. Pediatr Hematol Oncol. 2011;28:140–6.

    Article  PubMed  CAS  Google Scholar 

  2. Macdonald D, Aguiar RC, Mason PJ, Goldman JM, Cross NC. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia. 1995;9:1628–30.

    PubMed  CAS  Google Scholar 

  3. Bain BJ, Gilliland DG, Horny HP, Vardiman JW. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. In: Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 68–73.

    Google Scholar 

  4. Jackson CC, Medeiros LJ, Miranda RN. 8p11 myeloproliferative syndrome: a review. Hum Pathol. 2010;41:461–76.

    Article  PubMed  CAS  Google Scholar 

  5. Yang JJ, Park TS, Choi JR, Park SJ, Cho SY, Jun KR, et al. Submicroscopic deletion of FGFR1 gene is recurrently detected in myeloid and lymphoid neoplasms associated with ZMYM2-FGFR1 rearrangements: a case study. Acta Haematol. 2012;127:119–23.

    Article  PubMed  CAS  Google Scholar 

  6. Dolan M, Cioc A, Cross NC, Neglia JP, Tolar J. Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion. Pediatr Blood Cancer. 2012;59:194–6.

    Article  PubMed  Google Scholar 

  7. Chen J, Deangelo DJ, Kutok JL, Williams IR, Lee BH, Wadleigh M, et al. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci USA. 2004;101:14479–84.

    Article  PubMed  CAS  Google Scholar 

  8. Chase A, Grand FH, Cross NC. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome. Blood. 2007;110:3729–34.

    Article  PubMed  CAS  Google Scholar 

  9. Ren M, Qin H, Ren R, Cowell JK. Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities. Leukemia. 2013;27:32–40.

    Google Scholar 

  10. Lierman E, Smits S, Cools J, Dewaele B, Debiec-Rychter M, Vandenberghe P. Ponatinib is active against imatinib-resistant mutants of FIP1L1-PDGFRA and KIT, and against FGFR1-derived fusion kinases. Leukemia. 2012;26:1693–5.

    Article  PubMed  CAS  Google Scholar 

  11. Morishige S, Oku E, Takata Y, Kimura Y, Arakawa F, Seki R, et al. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation. Acta Haematol. 2012;129:83–9.

    Article  PubMed  Google Scholar 

  12. Nakayama H, Inamitsu T, Ohga S, Kai T, Suda M, Matsuzaki A, et al. Chronic myelomonocytic leukaemia with t(8;9)(p11;q34) in childhood: an example of the 8p11 myeloproliferative disorder? Br J Haematol. 1996;92:692–5.

    Article  PubMed  CAS  Google Scholar 

  13. Park TS, Song J, Kim JS, Yang WI, Song S, Kim SJ, et al. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality. Cancer Genet Cytogenet. 2008;181:93–9.

    Article  PubMed  CAS  Google Scholar 

  14. Zhou L, Fu W, Yuan Z, Hou J. Complete molecular remission after interferon alpha treatment in a case of 8p11 myeloproliferative syndrome. Leuk Res. 2010;34:306–7.

    Article  Google Scholar 

  15. Yamamoto K, Kawano H, Nishikawa S, Yakushijin K, Okamura A, Matsui T. A biphenotypic transformation of 8p11 myeloproliferative syndrome with CEP1/FGFR1 fusion gene. Eur J Haematol. 2006;77:349–54.

    Article  PubMed  CAS  Google Scholar 

  16. Wong WS, Cheng KC, Lau KM, Chan NP, Shing MM, Cheng SH, et al. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases. Leuk Res. 2007;31:235–8.

    Article  PubMed  CAS  Google Scholar 

  17. Matsumoto K, Morita K, Takada S, Sakura T, Shiozaki H, Murakami H. A chronic myelogenous leukemia-like myeloproliferative disorder accompanied by T-cell lymphoblastic lymphoma with chromosome translocation t(8;13)(p11;q12): a Japanese case. Int J Hematol. 1999;70:278–82.

    PubMed  CAS  Google Scholar 

  18. Lee SG, Park TS, Lee ST, Lee KA, Song J, Kim J, et al. Rare translocations involving chromosome band 8p11 in myeloid neoplasms. Cancer Genet Cytogenet. 2008;186:127–9.

    Article  PubMed  CAS  Google Scholar 

  19. Kim SY, Oh B, She CJ, Kim HK, Jeon YK, Shin MG. 8p11 myeloproliferative syndrome with BCR-FGFR1 rearrangement presenting with T-lymphoblastic lymphoma and bone marrow stromal cell proliferation: a case report and review of the literature. Leuk Res. 2011;35:30–4.

    Article  Google Scholar 

  20. Li F, Zhai YP, Tang YM, Wang LP, Wan PJ. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosom Cancer. 2012;51:890–7.

    Article  PubMed  CAS  Google Scholar 

  21. Yoshida C, Takeuchi M, Sadahira Y. A novel t(1;8)(q25;p11.2) translocation associated with 8p11 myeloproliferative syndrome. Br J Haematol. 2012;156:271–3.

    Article  PubMed  Google Scholar 

  22. Onozawa M, Ohmura K, Ibata M, Iwasaki J, Okada K, Kasahara I, et al. The 8p11 myeloproliferative syndrome owing to rare FGFR1OP2-FGFR1 fusion. Eur J Haematol. 2011;86:347–9.

    Article  PubMed  CAS  Google Scholar 

  23. Bae SY, Kim JS, Han EA, Lee HJ, Ryeu BJ, Lee KN, et al. Cytogenetic abnormality involving 8p11.2 in T-lymphoblastic lymphoma: report of a new case. Cancer Genet Cytogenet. 2009;191:57–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea

    Hyeyoung Lee, Myungshin Kim, Jihyang Lim, Yonggoo Kim & Kyungja Han

  2. Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea

    Byung-Sik Cho & Hee-Je Kim

Authors
  1. Hyeyoung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Myungshin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jihyang Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yonggoo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kyungja Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Byung-Sik Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hee-Je Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Myungshin Kim.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 21 kb)

About this article

Cite this article

Lee, H., Kim, M., Lim, J. et al. Acute myeloid leukemia associated with FGFR1 abnormalities. Int J Hematol 97, 808–812 (2013). https://doi.org/10.1007/s12185-013-1337-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-013-1337-5

Keywords

Search

Navigation